Annual SG&A
$17.45 M
-$3.11 M-15.11%
01 June 2022
Summary:
Pluristem Therapeutics annual selling, general & administrative expenses is currently $17.45 million, with the most recent change of -$3.11 million (-15.11%) on 01 June 2022. During the last 3 years, it has fallen by -$3.11 million (-15.11%).PSTI Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$2.74 M
-$781.00 K-22.18%
01 September 2022
Summary:
Pluristem Therapeutics quarterly selling, general & administrative expenses is currently $2.74 million, with the most recent change of -$781.00 thousand (-22.18%) on 01 September 2022.PSTI Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$1.46 B
-$35.93 M-2.52%
01 September 2022
Summary:
Pluristem Therapeutics TTM selling, general & administrative expenses is currently -$1.46 billion, with the most recent change of -$35.93 million (-2.52%) on 01 September 2022.PSTI TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PSTI Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | -15.1% | -46.1% | -6505.1% |
| 5 y5 years | +90.6% | +51.1% | -10000.0% |
PSTI Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | -15.1% | -58.2% | -6505.1% |
Pluristem Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | $2.74 M(-22.2%) | $15.10 M(-13.5%) |
| June 2022 | $17.45 M(-15.1%) | $3.52 M(-22.7%) | $17.45 M(-12.9%) |
| Mar 2022 | - | $4.55 M(+6.2%) | $20.03 M(-9.1%) |
| Dec 2021 | - | $4.29 M(-15.7%) | $22.04 M(-3.5%) |
| Sept 2021 | - | $5.09 M(-16.6%) | $22.85 M(+11.1%) |
| June 2021 | $20.56 M(+159.5%) | $6.10 M(-7.0%) | $20.56 M(+20.0%) |
| Mar 2021 | - | $6.56 M(+28.7%) | $17.13 M(+39.8%) |
| Dec 2020 | - | $5.10 M(+82.1%) | $12.26 M(+37.6%) |
| Sept 2020 | - | $2.80 M(+4.6%) | $8.91 M(+12.4%) |
| June 2020 | $7.92 M(-13.5%) | $2.68 M(+59.2%) | $7.92 M(+4.3%) |
| Mar 2020 | - | $1.68 M(-3.9%) | $7.60 M(-9.4%) |
| Dec 2019 | - | $1.75 M(-3.5%) | $8.39 M(-4.3%) |
| Sept 2019 | - | $1.81 M(-22.9%) | $8.76 M(-4.3%) |
| June 2019 | $9.16 M(-18.2%) | $2.35 M(-4.9%) | $9.16 M(-5.1%) |
| Mar 2019 | - | $2.47 M(+16.5%) | $9.65 M(-2.0%) |
| Dec 2018 | - | $2.12 M(-3.9%) | $9.84 M(-7.5%) |
| Sept 2018 | - | $2.21 M(-22.3%) | $10.64 M(-4.9%) |
| June 2018 | $11.19 M(+61.6%) | $2.84 M(+6.7%) | $11.19 M(+7.8%) |
| Mar 2018 | - | $2.67 M(-8.7%) | $10.38 M(+8.1%) |
| Dec 2017 | - | $2.92 M(+5.7%) | $9.60 M(+18.1%) |
| Sept 2017 | - | $2.76 M(+36.0%) | $8.13 M(+17.3%) |
| June 2017 | $6.93 M(+6.8%) | $2.03 M(+7.7%) | $6.93 M(+3.2%) |
| Mar 2017 | - | $1.89 M(+30.4%) | $6.71 M(+3.8%) |
| Dec 2016 | - | $1.45 M(-7.5%) | $6.46 M(-1.5%) |
| Sept 2016 | - | $1.56 M(-13.8%) | $6.56 M(+1.2%) |
| June 2016 | $6.49 M(+0.4%) | $1.81 M(+10.7%) | $6.49 M(+1.1%) |
| Mar 2016 | - | $1.64 M(+6.0%) | $6.41 M(+1.8%) |
| Dec 2015 | - | $1.55 M(+4.0%) | $6.30 M(+0.5%) |
| Sept 2015 | - | $1.49 M(-14.6%) | $6.27 M(-3.0%) |
| June 2015 | $6.46 M(-25.5%) | $1.74 M(+14.1%) | $6.46 M(-8.5%) |
| Mar 2015 | - | $1.53 M(+0.9%) | $7.06 M(-12.5%) |
| Dec 2014 | - | $1.51 M(-9.8%) | $8.06 M(-5.4%) |
| Sept 2014 | - | $1.68 M(-28.3%) | $8.53 M(-1.7%) |
| June 2014 | $8.68 M(+53.6%) | $2.34 M(-7.5%) | $8.68 M(+12.3%) |
| Mar 2014 | - | $2.53 M(+28.2%) | $7.72 M(+21.6%) |
| Dec 2013 | - | $1.98 M(+8.0%) | $6.35 M(+9.6%) |
| Sept 2013 | - | $1.83 M(+31.7%) | $5.80 M(+2.6%) |
| June 2013 | $5.65 M(-14.0%) | $1.39 M(+19.8%) | $5.65 M(-5.7%) |
| Mar 2013 | - | $1.16 M(-18.4%) | $5.99 M(-11.3%) |
| Dec 2012 | - | $1.42 M(-15.5%) | $6.76 M(+2.2%) |
| Sept 2012 | - | $1.68 M(-2.9%) | $6.61 M(+0.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2012 | $6.57 M(+46.4%) | $1.73 M(-10.0%) | $6.57 M(+6.5%) |
| Mar 2012 | - | $1.92 M(+50.9%) | $6.17 M(+14.3%) |
| Dec 2011 | - | $1.27 M(-22.1%) | $5.39 M(+0.5%) |
| Sept 2011 | - | $1.64 M(+23.0%) | $5.37 M(+19.6%) |
| June 2011 | $4.49 M(+42.9%) | $1.33 M(+15.5%) | $4.49 M(+15.6%) |
| Mar 2011 | - | $1.15 M(-7.5%) | $3.88 M(+11.0%) |
| Dec 2010 | - | $1.25 M(+64.8%) | $3.50 M(+11.9%) |
| Sept 2010 | - | $756.00 K(+4.3%) | $3.12 M(-0.4%) |
| June 2010 | $3.14 M(-8.2%) | $725.00 K(-5.6%) | $3.14 M(-4.1%) |
| Mar 2010 | - | $768.00 K(-12.2%) | $3.27 M(-2.4%) |
| Dec 2009 | - | $875.00 K(+13.6%) | $3.35 M(+3.1%) |
| Sept 2009 | - | $770.00 K(-10.5%) | $3.25 M(-6.7%) |
| June 2009 | $3.42 M(-43.4%) | $860.00 K(+1.2%) | $3.49 M(-13.2%) |
| Mar 2009 | - | $850.00 K(+9.8%) | $4.01 M(-15.1%) |
| Dec 2008 | - | $774.00 K(-22.8%) | $4.73 M(-13.8%) |
| Sept 2008 | - | $1.00 M(-27.7%) | $5.48 M(-9.2%) |
| June 2008 | $6.04 M(+62.0%) | $1.39 M(-11.2%) | $6.04 M(-5.3%) |
| Mar 2008 | - | $1.56 M(+2.3%) | $6.38 M(+7.2%) |
| Dec 2007 | - | $1.53 M(-1.9%) | $5.95 M(+22.0%) |
| Sept 2007 | - | $1.56 M(-9.9%) | $4.88 M(+30.9%) |
| June 2007 | $3.73 M(+260.5%) | $1.73 M(+52.1%) | $3.73 M(+57.5%) |
| Mar 2007 | - | $1.14 M(+149.1%) | $2.37 M(+59.5%) |
| Dec 2006 | - | $456.00 K(+12.3%) | $1.48 M(+20.5%) |
| Sept 2006 | - | $406.00 K(+10.5%) | $1.23 M(+19.1%) |
| June 2006 | $1.03 M(+18.3%) | $367.40 K(+45.0%) | $1.03 M(+26.9%) |
| Mar 2006 | - | $253.40 K(+24.3%) | $814.30 K(-2.9%) |
| Dec 2005 | - | $203.80 K(-2.4%) | $838.30 K(-6.9%) |
| Sept 2005 | - | $208.90 K(+41.0%) | $900.00 K(-6.0%) |
| June 2005 | $873.60 K(-79.2%) | $148.20 K(-46.6%) | $957.20 K(-75.5%) |
| Mar 2005 | - | $277.40 K(+4.5%) | $3.90 M(-13.5%) |
| Dec 2004 | - | $265.50 K(-0.2%) | $4.51 M(+2.2%) |
| Sept 2004 | - | $266.10 K(-91.4%) | $4.42 M(+4.6%) |
| June 2004 | $4.19 M(+3111.3%) | $3.10 M(+249.7%) | $4.22 M(+240.3%) |
| Mar 2004 | - | $885.30 K(+423.5%) | $1.24 M(+242.3%) |
| Dec 2003 | - | $169.10 K(+129.8%) | $362.60 K(+81.3%) |
| Sept 2003 | - | $73.60 K(-34.9%) | $200.00 K(+52.9%) |
| June 2003 | $130.60 K(+537.1%) | $113.00 K(+1537.7%) | $130.80 K(+388.1%) |
| Mar 2003 | - | $6900.00(+6.2%) | $26.80 K(+4.7%) |
| Dec 2002 | - | $6500.00(+47.7%) | $25.60 K(+34.0%) |
| Sept 2002 | - | $4400.00(-51.1%) | $19.10 K(+29.9%) |
| June 2002 | $20.50 K | $9000.00(+57.9%) | $14.70 K(+157.9%) |
| Mar 2002 | - | $5700.00 | $5700.00 |
FAQ
- What is Pluristem Therapeutics annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Pluristem Therapeutics?
- What is Pluristem Therapeutics quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Pluristem Therapeutics?
- What is Pluristem Therapeutics TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Pluristem Therapeutics?
What is Pluristem Therapeutics annual selling, general & administrative expenses?
The current annual SG&A of PSTI is $17.45 M
What is the all time high annual SG&A for Pluristem Therapeutics?
Pluristem Therapeutics all-time high annual selling, general & administrative expenses is $20.56 M
What is Pluristem Therapeutics quarterly selling, general & administrative expenses?
The current quarterly SG&A of PSTI is $2.74 M
What is the all time high quarterly SG&A for Pluristem Therapeutics?
Pluristem Therapeutics all-time high quarterly selling, general & administrative expenses is $6.56 M
What is Pluristem Therapeutics TTM selling, general & administrative expenses?
The current TTM SG&A of PSTI is -$1.46 B
What is the all time high TTM SG&A for Pluristem Therapeutics?
Pluristem Therapeutics all-time high TTM selling, general & administrative expenses is $22.85 M